Sodium Salicylate 40% Injection, compounded by Olympia Pharmacy, Orlando, FL Class II

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy 20130529 Ongoing
Distributed: Nationwide and PR
Sodium Iodide 20% Injection, compounded by Olympia Pharmacy, Orlando, FL Class II

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy 20130529 Ongoing
Distributed: Nationwide and PR
Sermorelin/GHRP 3 mg/3 mg vial, compounded by Olympia Pharmacy, Orlando, FL Class II

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy 20130529 Ongoing
Distributed: Nationwide and PR
Quadmix, compounded by Olympia Pharmacy, Orlando, FL Class II

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy 20130529 Ongoing
Distributed: Nationwide and PR
Progesterone EO 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Class II

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy 20130529 Ongoing
Distributed: Nationwide and PR
Progesterone 100 mg/ml in Olive Oil Injection, compounded by Olympia Pharmacy, Orlando, FL Class II

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy 20130529 Ongoing
Distributed: Nationwide and PR
Praziquantel 56.8mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Class II

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy 20130529 Ongoing
Distributed: Nationwide and PR
Potassium Phosphate Injection, compounded by Olympia Pharmacy, Orlando, FL Class II

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy 20130529 Ongoing
Distributed: Nationwide and PR
Polidocanol (0.75%, 1%, 3%, and 10%) Injection, compounded by Olympia Pharmacy, Orlando, FL Class II

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy 20130529 Ongoing
Distributed: Nationwide and PR
Phenylephrine 1 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Class II

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy 20130529 Ongoing
Distributed: Nationwide and PR
Page 1,694 of 1,805 | Showing 10 recalls
Data provided by openFDA